title: Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.
abstract: The objectives of this study were to identify unsolved issues in the management of invasive candidiasis, identify controversies and achieve consensus. The German Speaking Mycological Society (Deutschsprachige Mykologische Gesellschaft, DMykG e.V.) asked other German infectious diseases (ID) and mycological societies to submit unsolved issues concerning the diagnosis and treatment of fungal infections. Based on these contributions, a digital web-based questionnaire of 12 questions on Candida infections was designed to be completed by experts of the participating societies. Controversial results were identified by a mathematical model and were discussed at a consensus conference during the 43rd Annual Meeting of the DMykG e.V. in Cologne, Germany. Forty-two individuals completed the questionnaire. Analysis showed a strong consensus on treatment indications, choice of antifungals for clinical situations, handling of central venous catheters, duration of treatment and role of susceptibility testing. Opinions diverged on: initial treatment of haemodynamically stable neutropenic and haemodynamically unstable non-neutropenic patients, step down to oral treatment and the differential role of the echinocandins. These questions were presented for discussion at the expert consensus conference. In three of four questions, consensus was achieved. A two-step approach - web-based survey plus classical panel discussion - allows to capture expeditiously the opinions of a large and diverse group of individuals, to identify controversial issues and to resolve them in a personal, interactive setting. Thus, expert consensus was achieved on nine of 12 important questions on how to treat invasive candidiasis.
authors.affiliation: Cancer Center Munich South, Klinikum Neuperlach and Harlaching, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Karthaus
authors.forename: M J G T
authors.initials: MJ
authors.lastname: Rüping
authors.forename: O A
authors.initials: OA
authors.lastname: Cornely
authors.forename: A
authors.initials: A
authors.lastname: Steinbach
authors.forename: A H
authors.initials: AH
authors.lastname: Groll
authors.forename: C
authors.initials: C
authors.lastname: Lass-Flörl
authors.forename: H
authors.initials: H
authors.lastname: Ostermann
authors.forename: M
authors.initials: M
authors.lastname: Ruhnke
authors.forename: J J
authors.initials: JJ
authors.lastname: Vehreschild
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D058365:Candidiasis, Invasive / Q000175:diagnosis* / Q000188:drug therapy*; D003245:Consensus Statements as Topic; D003625:Data Collection; D005858:Germany; D006801:Humans; D020407:Internet; D008826:Microbial Sensitivity Tests; D011795:Surveys and Questionnaires
chemical_list: D000935:Antifungal Agents